Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL
Clinical trial NCT02212379 · COMPLETED
Trial details
- NCT number
- NCT02212379
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2017-10-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.